Back to Journals » Breast Cancer: Targets and Therapy » Volume 15

Can Patients with HER2-Low Breast Cancer Benefit from Anti-HER2 Therapies? A Review

Total article views   HTML views PDF downloads Totals
7,650 Dovepress* 6,650+ 162 6,812
PubMed Central* 1,000 222 1,222
Totals 7,650 384 8,034
*Since 21 April 2023
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 2 3

View citations on PubMed Central and Google Scholar